Increased SIRT6 epigenetically promotes acetyl-CoA acetyltransferase 2 (ACAT2) expression, redirecting lipid metabolism toward free cholesterol accumulation—a hallmark of ccRCC aggressiveness. Here, SIRT6 is linked to nonpapillary renal cell carcinoma.